Key result
A recombinant Trypanosoma cruzi antigen, JL5, containing a peptide homologous to the human P ribosomal protein, reacted predominantly with sera from patients with overt Chagas' heart disease.
Observational (n=60)
The identification of the T. cruzi P ribosomal protein antigen JL5, which reacts predominantly with sera from Chagas' heart disease patients and shares homology with an SLE autoantigen, suggests a potential autoimmune mechanism in chagasic cardiomyopathy.
Suggests autoimmune cross-reactivity in Chagas cardiomyopathy; leaves open causal confirmation in human studies.
To identify Trypanosoma cruzi target antigens in overt Chagas' heart disease, a parasite lambda gt11 cDNA library was screened with the serum of a patient with a severe chagasic heart involvement (JL). Using a phage dot array immunoassay, 5 highly antigenic clones, JL1, JL5, JL7, JL8, and JL9, were probed with sera from clinically characterized T. cruzi infected subjects. The correlation of cloned T. cruzi antigen recognition with the clinical status of the subjects led to the identification of a recombinant antigen, JL5, that reacted predominantly with sera from patients with Chagas' heart disease. The antigenic determinant of the JL5 recombinant was a small 35 amino acid peptide. The nucleotide and the deduced amino acid sequence, together with other experimental data, allowed identification as the C-terminal portion of a T. cruzi P ribosomal protein. The C-terminal undecapeptide in JL5, EDDDMGFGLFD, was highly homologous to the same region of the human P protein SD(D/E)DMGFGLFD. The latter sequence has been identified as the P protein epitope in systemic lupus erythematosus (SLE). Positive SLE sera reacted with the JL5 recombinant phage, suggesting that the T. cruzi P protein might induce antibodies with a similar specificity to that of P antibodies in SLE.
No takes yet. Share an insight, caveat, or question.
Levin et al. (1989) conducted an observational in Chagas' heart disease (n=60). Trypanosoma cruzi infection with overt heart disease vs. Chronically infected individuals without heart disease and uninfected controls was evaluated on Reactivity of recombinant antigen JL5 with patient sera. A recombinant Trypanosoma cruzi antigen, JL5, containing a peptide homologous to the human P ribosomal protein, reacted predominantly with sera from patients with overt Chagas' heart disease.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: